Efficacy and Safety of Bictegravir-Based Regimen in Pregnant Women Living with HIV: A Case Report

Bictegravir (BIC) is included in international guidelines as the first line of therapy for patients living with Human Immunodeficiency Virus (HIV), either as initial therapy or as a replacement for patients with prior antiretroviral therapy (ART). Due to limited efficacy and safety data, BIC is curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsulami, Shaimaa, Alotaibi, Sultan N., Damfu, Nader, Aljefri, Doaa M., Altayib, Hadeel Ahmed, Alharbi, Maher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772963/
https://www.ncbi.nlm.nih.gov/pubmed/36529886
http://dx.doi.org/10.1177/23259582221146110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772963/
https://www.ncbi.nlm.nih.gov/pubmed/36529886
http://dx.doi.org/10.1177/23259582221146110

Ejemplares similares